Reduction of Early Reperfusion Injury With the Mitochondria-Targeting Peptide Bendavia

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Cardiovascular Pharmacology and Therapeutics

• Publication date

  2014-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1074248413508003PMID 24288396PMCID PMC4103197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin.

  2013cited by this paper
• Two Classes of Anti-Platelet Drugs Reduce Anatomical Infarct Size in Monkey Hearts

  2013cited by this paper
• Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary interventi

  2013cited by this paper
• BENDAVIA (MTP-131), A NOVEL MITOCHONDRIA-TARGETING PEPTIDE, IMPROVES ACTIVITY AND EXPRESSION OF CYTOCHROME-C OXIDASE AND ATTENUATES MEDIATORS OF CARDIOMYOCYTE APOPTOSIS IN LEFT VENTRICULAR MYOCARDIUM OF DOGS WITH ADVANCED HEART FAILURE

  2013cited by this paper
• Cardioprotection: chances and challenges of its translation to the clinic.

  2013cited by this paper
• Redox-dependent increases in glutathione reductase and exercise preconditioning: role of NADPH oxidase and mitochondria.

  2013cited by this paper
• Mitochondrial inner membrane lipids and proteins as targets for decreasing cardiac ischemia/reperfusion injury.

  2013cited by this paper
• Coronary no reflow.

  2012cited by this paper
• Reduction of Ischemia/Reperfusion Injury With Bendavia, a Mitochondria-Targeting Cytoprotective Peptide

  2012influential reference
• Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury.

  2012cited by this paper
• Mitochondria as a Drug Target in Ischemic Heart Disease and Cardiomyopathy

  2012cited by this paper
• Phosphate is not an absolute requirement for the inhibitory effects of cyclosporin A or cyclophilin D deletion on mitochondrial permeability transition.

  2012cited by this paper
• How and When Do Myocytes Die During Ischemia and Reperfusion: The Late Phase

  2011cited by this paper
• A fluorescence approach to investigate repartitioning of coalescing agents in acrylic polymer emulsions

  2011cited by this paper
• New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop.

  2011cited by this paper
• The Mitochondrial Permeability Transition Pore and the Cardiac Necrotic Program

  2011cited by this paper
• Novel Therapies Targeting Inner Mitochondrial Membrane—From Discovery to Clinical Development

  2011cited by this paper
• Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury.

  2011cited by this paper
• High doses of ketamine-xylazine anesthesia reduce cardiac ischemia-reperfusion injury in guinea pigs.

  2011cited by this paper
• Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.

  2011cited by this paper
• Short-term exercise preserves myocardial glutathione and decreases arrhythmias after thiol oxidation and ischemia in isolated rat hearts.

  2011cited by this paper
• State of the Science of Cardioprotection: Challenges and Opportunities— Proceedings of the 2010 NHLBI Workshop on Cardioprotection

  2011cited by this paper
• Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion

  2010cited by this paper
• Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection

  2010cited by this paper
• Cardiac preconditioning for ischaemia: lost in translation

  2010cited by this paper
• Cyclosporine A at Reperfusion Reduces Infarct Size in Pigs

  2010cited by this paper
• Cardiac mitochondria and arrhythmias.

  2010cited by this paper
• Cardiac arrhythmias induced by glutathione oxidation can be inhibited by preventing mitochondrial depolarization.

  2010cited by this paper
• Hydrogen peroxide is the major oxidant product of xanthine oxidase.

  2010cited by this paper
• Cardioprotection With Adenosine-Regulating Agent, GP531: Effects on No-Reflow, Infarct Size, and Blood Flow Following Ischemia/ Reperfusion in the Rabbit

  2010cited by this paper
• Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans.

  2009cited by this paper
• Why do we still not have cardioprotective drugs?

  2009cited by this paper
• What is the mitochondrial permeability transition pore?

  2009cited by this paper
• Kinetic studies on enzyme-catalyzed reactions: oxidation of glucose, decomposition of hydrogen peroxide and their combination.

  2009cited by this paper
• The role of the mitochondrial permeability transition pore in heart disease.

  2009cited by this paper
• The mitochondrial permeability transition pore and ischemia-reperfusion injury

  2009cited by this paper
• Comparison of the protective effect of N-acetylcysteine by different treatments on rat myocardial ischemia-reperfusion injury.

  2008cited by this paper
• Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

  2008cited by this paper
• Radical-free biology of oxidative stress.

  2008cited by this paper
• Effect of cyclosporine on reperfusion injury in acute myocardial infarction.

  2008cited by this paper
• Mitochondria-Targeted Cytoprotective Peptides for Ischemia–Reperfusion Injury

  2008cited by this paper
• Glutathione oxidation as a trigger of mitochondrial depolarization and oscillation in intact hearts.

  2008cited by this paper
• Cyclosporine preserves mitochondrial morphology after myocardial ischemia/reperfusion independent of calcineurin inhibition.

  2008cited by this paper
• Role of cardiolipin alterations in mitochondrial dysfunction and disease.

  2007cited by this paper
• A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death.

  2006cited by this paper
• Real-Time 2-Photon Imaging of Mitochondrial Function in Perfused Rat Hearts Subjected to Ischemia/Reperfusion

  2006cited by this paper
• Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology

  2005cited by this paper
• Ischemic preconditioning protects by activating prosurvival kinases at reperfusion.

  2005cited by this paper
• Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion.

  2004cited by this paper
• Effects of edaravone on reperfusion injury in patients with acute myocardial infarction.

  2004cited by this paper
• Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection.

  2004cited by this paper
• Myocardial Protection at a Crossroads: The Need for Translation Into Clinical Therapy

  2004cited by this paper
• Cell-permeable Peptide Antioxidants Targeted to Inner Mitochondrial Membrane inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusion Injury*

  2004cited by this paper
• The Preconditioning Phenomenon A Tool for the Scientist or a Clinical Reality ?

  2000cited by this paper
• Volatile Anesthetics Protect the Ischemic Rabbit Myocardium from Infarction

  1997cited by this paper
• Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality.

  1995cited by this paper
• Effects of N-acetylcysteine in the rat heart reperfused after low-flow ischemia: evidence for a direct scavenging of hydroxyl radicals and a nitric oxide-dependent increase in coronary flow.

  1995cited by this paper
• Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction.

  1994cited by this paper
• Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium.

  1994cited by this paper
• Protective effects of the SOD-mimetic SC-52608 against ischemia/reperfusion damage in the rabbit isolated heart.

  1994cited by this paper
• Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioning.

  1994cited by this paper
• Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart

  1991cited by this paper
• Cardioprotective effects of N-acetylcysteine: the reduction in the extent of infarction and occurrence of reperfusion arrhythmias in the dog.

  1990cited by this paper
• Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage.

  1989cited by this paper
• Effect of N-acetylcysteine on tissue necrosis during acute myocardial infarction in rabbits.

  1989cited by this paper
• Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog.

  1989cited by this paper
• Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium").

  1988cited by this paper
• Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy.

  1987cited by this paper
• KINETICS AND MECHANISM OF ACTION OF GLUCOSE OXIDASE.

  1964cited by this paper

• Emerging Frontiers in Antioxidant Therapeutics: From Nanotechnology-Enabled Delivery to Mitochondria-Targeted Interventions

  2026cites this paper
• Mitochondrial dysfunction in refractory angina: therapeutic rationale for cardiolipin stabilization with elamipretide

  2026cites this paper
• Current status and future directions of colorectal cancer screening: can colonoscopy be replaced?

  2025cites this paper
• Contemporary insights into elamipretide’s mitochondrial mechanism of action and therapeutic effects

  2025cites this paper
• Mitochondria for Cardiovascular Therapy: A Deep Dive into Drug Targets and Therapeutic Approaches

  2025cites this paper
• Mitochondrial targets in ischaemic heart disease and heart failure, and their potential for a more efficient clinical translation. A scientific statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function

  2025cites this paper
• Mechanisms of postischemic cardiac death and protection following myocardial injury

  2025cites this paper
• Surgical Stress and Liver Response: Injury, Regeneration, and Protection.

  2025cites this paper
• Targeting mitochondrial fission for the treatment of myocardial infarction.

  2025cites this paper
• Mitofilin in Cardiovascular Diseases: Insights into the Pathogenesis and Potential Pharmacological Interventions.

  2024cites this paper
• Sex differences in cardiac mitochondrial respiration and reactive oxygen species production may predispose Scn1a−/+ mice to cardiac arrhythmias and Sudden Unexpected Death in Epilepsy

  2024cites this paper
• Mitochondrial reactive oxygen species cause arrhythmias in hypertrophic cardiomyopathy

  2024cites this paper
• Decreased ability to manage increases in reactive oxygen species may underlie susceptibility to arrhythmias in mice lacking Scn1b.

  2024cites this paper
• Elamipretide Topical Ophthalmic Solution for the Treatment of Subjects With Leber's Hereditary Optic Neuropathy: A Randomized Trial.

  2023cites this paper
• Mitochondria in cell senescence: A Friend or Foe?

  2023cites this paper
• Elamipretide mitigates ischemia-reperfusion injury in a swine model of hemorrhagic shock

  2023cites this paper
• MAPK Signaling Pathways in Hepatic Ischemia/Reperfusion Injury

  2023cites this paper
• Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy

  2023cites this paper
• Interventions with Potential to Mitigate Injection Site Reactions Following Subcutaneous Elamipretide Administration: A Phase 1, Crossover Study

  2023cites this paper
• Mitochondrial Targeted Interventions for Aging.

  2023cites this paper
• Reactive Oxygen Species Induced Pathways in Heart Failure Pathogenesis and Potential Therapeutic Strategies

  2022cites this paper
• Mitochondria as Therapeutic Targets in Heart Failure

  2022cites this paper
• Heart Failure

  2022cites this paper
• Mitochondrial calcium and reactive oxygen species in cardiovascular disease.

  2022cites this paper
• Mitochondrial Dysfunction and Cardiovascular Disease: Pathophysiology and Emerging Therapies

  2022cites this paper
• Teriflunomide treatment exacerbates cardiac ischemia reperfusion injury in isolated rat hearts

  2022cites this paper
• Shaping of Hepatic Ischemia/Reperfusion Events: The Crucial Role of Mitochondria

  2022cites this paper
• Studies of the cardiolipin interactome.

  2022cites this paper
• Hereditary Optic Neuropathies

  2021cites this paper
• Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets

  2021cites this paper
• S-allylcysteine improves ischemia/reperfusion alteration on cardiac function, antioxidant, and mitochondrial permeability.

  2021cites this paper
• Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid

  2021cites this paper
• Selective NADH communication from α-ketoglutarate dehydrogenase to mitochondrial transhydrogenase prevents reactive oxygen species formation under reducing conditions in the heart

  2020cites this paper
• A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy

  2020cites this paper
• Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice

  2020cites this paper
• The mitochondrial permeability transition phenomenon elucidated by cryo-EM reveals the genuine impact of calcium overload on mitochondrial structure and function

  2020cites this paper
• Restoring mitochondrial superoxide levels with elamipretide (MTP-131) protects db/db mice against progression of diabetic kidney disease

  2020cites this paper
• DHA Supplementation Attenuates MI-Induced LV Matrix Remodeling and Dysfunction in Mice

  2020cites this paper
• Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets

  2020cites this paper
• The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats

  2020cites this paper
• The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats

  2020cites this paper
• Mitochondria-Targeted Drug Delivery in Cardiovascular Disease: A Long Road to Nano-Cardio Medicine

  2020cites this paper
• Riding the tiger – physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix

  2020cites this paper
• Impact of prolonged nicotine administration on myocardial function and susceptibility to ischaemia‐reperfusion injury in rats

  2020cites this paper
• In vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial

  2020cites this paper
• Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide

  2020cites this paper
• Mitochondrial dysfunction in cardiovascular disease: Current status of translational research/clinical and therapeutic implications

  2020cites this paper
• Mitochondrial targeted therapy with elamipretide (MTP-131) as an adjunct to tumor necrosis factor inhibition for traumatic optic neuropathy in the acute setting.

  2020cites this paper
• Metabolomic biomarkers from patients with Barth syndrome treated with elamipretide: insights from the TAZPOWER study

  2020cites this paper
• Cellular and molecular approaches to enhance myocardial recovery after myocardial infarction.

  2019cites this paper
• Metabolic Resuscitation Strategies to Prevent Organ Dysfunction in Sepsis

  2019cites this paper
• Investigational drugs in phase II clinical trials for acute coronary syndromes

  2019cites this paper
• Effects of elamipretide on skeletal muscle in dogs with experimentally induced heart failure

  2019cites this paper
• Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure—A Report from the 2018 National Heart, Lung, and Blood Institute Workshop

  2019cites this paper
• Mitochondrial dysfunction and oxidative stress in heart disease

  2019cites this paper
• Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection.

  2018cites this paper
• Increased Survival Time With SS-31 After Prolonged Cardiac Arrest in Rats.

  2018influential citation
• Novel Insights and Treatment Strategies for Right Heart Failure

  2018cites this paper
• Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy

  2018cites this paper
• Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure

  2018cites this paper
• Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide

  2018cites this paper
• Mitochondria-Targeted Antioxidants and Skeletal Muscle Function

  2018cites this paper
• Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles

  2018cites this paper
• Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 β-cells.

  2018cites this paper
• Mitochondrial dysfunction and metabolic intervention

  2017cites this paper
• Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series.

  2017cites this paper
• Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure

  2017influential citation
• Treatment of Leber's Hereditary Optic Neuropathy.

  2017cites this paper
• The role of succinate and ROS in reperfusion injury – A critical appraisal

  2017cites this paper
• Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction Still Awaiting Translation

  2017cites this paper
• Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart

  2017cites this paper
• New and revisited approaches to preserving the reperfused myocardium

  2017cites this paper
• Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options.

  2017cites this paper
• Advance Publication Experimental Animals

  2017cites this paper
• Mitochondrial-Targeted Catalase: Extended Longevity and the Roles in Various Disease Models.

  2017cites this paper
• The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age.

  2017cites this paper
• Mitochondrial energetics and calcium coupling in the heart

  2017cites this paper
• An increasing electromechanical window is a predictive marker of ventricular fibrillation in anesthetized rabbit with ischemic heart

  2017cites this paper
• Mitochondrial Therapies in Heart Failure.

  2017cites this paper
• The metabolic syndrome induces early changes in the swine renal medullary mitochondria

  2017cites this paper
• Protective roles of bioactive peptides during ischemia‐reperfusion injury: From bench to bedside

  2017cites this paper
• Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction

  2016cites this paper
• Astragalus Salvia Granules to Benefit the Qi (Qishen Yiqi Keli) protects H9C2 cardiomyocytes by suppressing oxidative stress

  2016cites this paper
• Chapter 17 – Cardiac Aging

  2016cites this paper
• Compartment-specific Control of Reactive Oxygen Species Scavenging by Antioxidant Pathway Enzymes*

  2016cites this paper
• The mitochondrial permeability transition pore in AD 2016: An update.

  2016cites this paper
• Defective postreperfusion metabolic recovery directly associates with incident delayed graft function.

  2016cites this paper
• Hepatic ischemia reperfusion injury: A systematic review of literature and the role of current drugs and biomarkers.

  2016cites this paper
• Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure

  2016cites this paper
• Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion Injury

  2016cites this paper
• Mitochondrial function as a therapeutic target in heart failure

  2016cites this paper
• Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion

  2016cites this paper
• EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention.

  2016cites this paper
• Mitochondrial therapy improves limb perfusion and myopathy following hindlimb ischemia.

  2016cites this paper
• Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches.

  2016cites this paper
• Cardiolipin alterations and mitochondrial dysfunction in heart ischemia/reperfusion injury

  2015cites this paper
• Inherited cardiomyopathies--Novel therapies.

  2015cites this paper
• Mitochondria as Key Targets of Cardioprotection in Cardiac Ischemic Disease: Role of Thyroid Hormone Triiodothyronine

  2015cites this paper
• Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders.

  2015cites this paper
• Advances in therapeutic strategies for Leber’s hereditary optic neuropathy

  2015cites this paper